These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27546448)

  • 1. Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia.
    Lindorfer MA; Cook EM; Reis ES; Ricklin D; Risitano AM; Lambris JD; Taylor RP
    Clin Immunol; 2016 Oct; 171():32-35. PubMed ID: 27546448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria.
    Pawluczkowycz AW; Lindorfer MA; Waitumbi JN; Taylor RP
    J Immunol; 2007 Oct; 179(8):5543-52. PubMed ID: 17911641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy.
    Zhang Y; Shao D; Ricklin D; Hilkin BM; Nester CM; Lambris JD; Smith RJ
    Immunobiology; 2015 Aug; 220(8):993-8. PubMed ID: 25982307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts.
    Fiane AE; Mollnes TE; Videm V; Hovig T; Høgåsen K; Mellbye OJ; Spruce L; Moore WT; Sahu A; Lambris JD
    Xenotransplantation; 1999 Feb; 6(1):52-65. PubMed ID: 10355733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia.
    Oyong DA; Kenangalem E; Poespoprodjo JR; Beeson JG; Anstey NM; Price RN; Boyle MJ
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malarial anemia: digestive vacuole of Plasmodium falciparum mediates complement deposition on bystander cells to provoke hemophagocytosis.
    Dasari P; Fries A; Heber SD; Salama A; Blau IW; Lingelbach K; Bhakdi SC; Udomsangpetch R; Torzewski M; Reiss K; Bhakdi S
    Med Microbiol Immunol; 2014 Dec; 203(6):383-93. PubMed ID: 24985035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.
    Odhiambo CO; Otieno W; Adhiambo C; Odera MM; Stoute JA
    BMC Med; 2008 Aug; 6():23. PubMed ID: 18717995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes.
    Arese P; Turrini F; Schwarzer E
    Cell Physiol Biochem; 2005; 16(4-6):133-46. PubMed ID: 16301814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properdin binding to complement activating surfaces depends on initial C3b deposition.
    Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3.
    Sahu A; Morikis D; Lambris JD
    Mol Immunol; 2003 Jan; 39(10):557-66. PubMed ID: 12431389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3.
    Soulika AM; Holland MC; Sfyroera G; Sahu A; Lambris JD
    Mol Immunol; 2006 May; 43(12):2023-9. PubMed ID: 16472861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention of uninfected red blood cells causing congestive splenomegaly is the major mechanism of anemia in malaria.
    Kho S; Siregar NC; Qotrunnada L; Fricot A; Sissoko A; Shanti PAI; Candrawati F; Kambuaya NN; Rini H; Andries B; Hardy D; Margyaningsih NI; Fadllan F; Rahmayenti DA; Puspitasari AM; Aisah AR; Leonardo L; Yayang BTG; Margayani DS; Prayoga P; Trianty L; Kenangalem E; Price RN; Yeo TW; Minigo G; Noviyanti R; Poespoprodjo JR; Anstey NM; Buffet PA
    Am J Hematol; 2024 Feb; 99(2):223-235. PubMed ID: 38009287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of malarial anaemia: potential involvement of the Plasmodium falciparum low molecular weight rhoptry-associated proteins.
    Awah NW; Troye-Blomberg M; Berzins K; Gysin J
    Acta Trop; 2009 Dec; 112(3):295-302. PubMed ID: 19695213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.
    Baas I; Delvasto-Nuñez L; Ligthart P; Brouwer C; Folman C; Reis ES; Ricklin D; Lambris JD; Wouters D; de Haas M; Jongerius I; Zeerleder SS
    Haematologica; 2020; 105(2):e57-e60. PubMed ID: 31171642
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of malaria heme products on red blood cell deformability.
    Nuchsongsin F; Chotivanich K; Charunwatthana P; Omodeo-Salè F; Taramelli D; Day NP; White NJ; Dondorp AM
    Am J Trop Med Hyg; 2007 Oct; 77(4):617-22. PubMed ID: 17978059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors.
    Lamers C; Xue X; Smieško M; van Son H; Wagner B; Berger N; Sfyroera G; Gros P; Lambris JD; Ricklin D
    Nat Commun; 2022 Sep; 13(1):5519. PubMed ID: 36127336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of fluid phase C3b to nonsensitized bystander human red cells. A model for in vivo effects of complement activation on blood cells.
    Salama A; Mueller-Eckhardt C
    Transfusion; 1985; 25(6):528-34. PubMed ID: 3907025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia.
    Stoute JA; Odindo AO; Owuor BO; Mibei EK; Opollo MO; Waitumbi JN
    J Infect Dis; 2003 Feb; 187(3):522-5. PubMed ID: 12552440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid supplementation confers protection to red blood cells before Plasmodium falciparum bystander stress.
    Binns HC; Alipour E; Sherlock CE; Nahid DS; Whitesides JF; Cox AO; Furdui CM; Marrs GS; Kim-Shapiro DB; Cordy RJ
    Blood Adv; 2024 May; 8(10):2552-2564. PubMed ID: 38537079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.
    Nilsson B; Larsson R; Hong J; Elgue G; Ekdahl KN; Sahu A; Lambris JD
    Blood; 1998 Sep; 92(5):1661-7. PubMed ID: 9716594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.